BioSpace News Archive

Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone following receipt of FDA Investigational Device Exemption approval to conduct a staged pivotal clinical trial for its Duett Vascular Graft System in the United States.

Johnson & Johnson announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. common stock owned by Johnson & Johnson.

Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that Sean Brynjelsen, Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference in New York City as follows.

Asensus Surgical, Inc. announced that First Towakai Hospital has entered into an agreement to lease and utilize a Senhance® Surgical System in their urology and gynecology centers and gastroenterology department.

Immix Biopharma, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) designation for NXC-201 for the treatment of a life-threatening form of blood cancer, multiple myeloma.

Emmaus Life Sciences, Inc. today reported that on August 18, 2023 the Board of Directors, including Yutaka Niihara, M.D., Ph.D, determined that Dr. Niihara would no longer serve as Chief Executive Officer of Emmaus, or as Chairman of the Board, in order to allow Dr. Niihara to pursue business opportunities in Ube, Japan and in India previously initiated by Emmaus.

GRI Bio, Inc. today announced that the Company has entered into an asset purchase agreement pursuant to which Aardvark Therapeutics, Inc. (“Aardvark”) will acquire certain assets and intellectual property of the Company that pertain to ADAIR (Abuse Deterrent Amphetamine Immediate Release).

Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Barbara Gutierrez has agreed to join Modivcare as its Chief Financial Officer (CFO) with an expected start date of September 18, 2023.

Operio Group has today announced its hiring of Deb Blackwell as its newest Chief Revenue Officer (CRO).

Whitman-Walker Institute, Cancer Support Community, and GRAIL, LLC announced a research collaboration aimed at advancing health equity in cancer screening and care with GalleriⓇ, a multi-cancer early detection test, in diverse patient populations.